ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconFacebook IconIcon FacebookGoogle Plus IconLayer 1InstagramCreated with Sketch.Linkedin IconIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintRSS IconIcon SearchSite TitleTitle ChevronTwitter IconIcon TwitterYoutube Icon
Consumer Non-Durables

Dabur India Ltd.

  • 453.00 INR
  • +8.10
  • +1.82%
  • India
    Aug 16, 2018
  • Ticker
  • Prev. close
  • Market cap (INR)
  • Market cap (USD)
  • Shares

Company Background

The world's largest ayurvedic and natural health care company, Dabur India is building its presence in the global consumer goods business. The company was founded by S.K. Burman in 1884. It started as an ayurvedic medicine business in a small pharmacy in eastern Kolkata. In the local language, Burman was commonly called Daktar Burman (Doctor Burman); the company's name combines the syllables "da" and "bur."

Today, Dabur India's products are available in more than 60 countries and span categories including hair care, skin care, health care and food. About 68% of its shares are held by the Burman family, which lets employees run the show. The company has subsidiaries in countries such as the U.K, Nepal, Egypt and Turkey; international sales make up 30% of the consolidated total.

Sunil Duggal, an electrical and electronics engineering graduate, has served as CEO since June 2002. Prior to joining Dabur India's family products division as general manager of sales and marketing in 1995, he worked for businesses such as Wimco and Pepsi Foods.

Dabur's second-biggest brand, Vatika, focuses on hair care. Launched when Duggal was in the family products division, the brand became a major growth engine for the company.

Business Summary

Dabur India Ltd. engages in the provision of hair care, oral care, skin care, health care, home care, and food products. It operates through the following segments: Consumer Care Business, Foods Business, and Other. The Consumer Care Business segment involves in providing Home care, personal care and health care. The Foods Business segment offers packaged fruit juices, beverages, and culinary. The Others segment includes guar gum, pharma, and others. The company was founded by Saket K. Burma in 1884 and is headquartered in Ghaziabad, India.

Financial Highlights

Mar 2018 INRUSD
Gross Profit26,929.50M417.73M
Operating income14,638.80M227.07M
Income before tax16,930.90M262.63M
Net income13,543.90M210.09M
Diluted EPS7.660.11
Dividends Per Share2.500.03
Total Assets87,016.30M1,334.16M
Total liabilities29,685.80M455.15M
Total equity57,065.20M874.94M
Operating cash flow12,899.10M200.09M
Currency in INRCurrency in USD

Historical Data

 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 70,370.70M 77,747.60M 77,774.20M 76,103M 76,774M
Gross Profit 27,643.50M 30,634.90M 29,320.10M 26,916.60M 26,929.50M
Operating income 10,432.80M 11,937.60M 13,990.20M 14,045.90M 14,638.80M
Income before tax 11,355.30M 13,193.60M 15,538M 16,106.50M 16,930.90M
Net income 9,139.20M 10,658.30M 12,511.50M 12,769.40M 13,543.90M
EBITDA 11,407.70M 13,087.40M 15,308.70M 15,462.60M 16,249.50M
Diluted EPS 5.21 6.03 7.07 7.21 7.66
Dividends Per Share 1.75 2 2.25 2.25 2.50
Total Assets 59,702.20M 68,720.40M 78,227.20M 77,322.40M 87,016.30M
Total liabilities 32,983.50M 34,997.40M 36,304M 28,600.80M 29,685.80M
Total equity 26,559.60M 33,541.40M 41,706.10M 48,473.90M 57,065.20M
Operating cash flow 11,620.50M 11,174.40M 12,950.80M 13,719.40M 12,899.10M
 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 1,164.41M 1,271.56M 1,187.92M 1,134.89M 1,190.92M
Gross Profit 457.41M 501.03M 447.83M 401.39M 417.73M
Operating income 172.63M 195.23M 213.68M 209.46M 227.07M
Income before tax 187.89M 215.78M 237.32M 240.19M 262.63M
Net income 151.22M 174.31M 191.10M 190.42M 210.09M
EBITDA 188.76M 214.04M 233.82M 230.58M 252.06M
Diluted EPS 0.08 0.09 0.10 0.10 0.11
Dividends Per Share 0.02 0.03 0.03 0.03 0.03
Total Assets 999.66M 1,098.09M 1,181.27M 1,190.76M 1,334.16M
Total liabilities 552.27M 559.23M 548.21M 440.45M 455.15M
Total equity 444.71M 535.96M 629.78M 746.49M 874.94M
Operating cash flow 192.28M 182.75M 197.81M 204.59M 200.09M

Valuation Measures

Mar 2018
Operating margin19.06%
Profit margin17.64%

Key executives

  • Chief Executive Officer & Executive Director: Sunil Duggal
  • Executive Director-Operations: Shahrukh Khan Adi
  • Chief Financial Officer: Lalit Malik
  • Secretary, VP-Finance & Compliance Officer: Ashok Kumar Jain
  • Executive Director & Director-Corporate Affairs: Pritam Das Narang


  • BURMAN ASHA (11.4%)
  • BURMAN PRADIP (8.9%)
  • BURMAN MONICA (3.0%)
  • First State Investment Management (UK) Ltd. (1.6%)
  • BURMAN GAURAV V (1.5%)
  • Aditya Birla Sun Life AMC Ltd. (1.3%)

Contact Details

  • Website:
  • Address: Dabur Corporate Office, Kaushambi, Ghaziabad, 201010, India
  • Phone: +91.120.3982100

Related Companies

  • Dabur Lanka Pvt Ltd.
  • Naturelle LLC
  • Dabur Egypt Trading Ltd.
  • Dabur Pharmaceuticals Ltd.
  • Dabur Egypt Ltd.
  • Dabur Oncology Plc
  • Dabur International Ltd. (United Kingdom)
  • Dermoviva Skin Essentials, Inc.
  • Dabur Foods Ltd.
  • Dabur International Ltd.
  • Dabur Finance Ltd.
  • Fem Care Pharma Ltd.
  • Besta Cosmetics Ltd.
  • Balsara Hygiene Products Ltd.
  • Balsara Home Products, Ltd.
  • Shri Dhanwantry Educational Society
  • Excelsia Foods Ltd
  • Redrock Ltd


  • Hemas Holdings Ltd.
  • Bajaj Corp Limited
  • Agro Tech Foods Limited
Last Updated on 16 Aug, 2018

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

3 months for $9

Get unlimited access
NAR site on phone, device, tablet

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media